← All trials
NCT01945619
N/AExpanded Access
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 16, 2013
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Baylor UniversityLead sponsor
- Baylor UniversityOverall official - principal investigator
- Duke UniversityCollaborator
- New York Medical CollegeCollaborator
- Children's National Medical CenterCollaborator
- University of Southern CaliforniaCollaborator
- Baylor UniversityCollaborator
- The University of Texas, DallasCollaborator
- Baylor UniversityReponsible party - principal investigator
- Johns Hopkins UniversityCollaborator
- Rutgers UniversityCollaborator
- Methodist Cancer Center, Houston, TexasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.